Biologic Agent-Associated Cutaneous Adverse Events: A Single Center Experience
Biologic Agent-Associated Cutaneous Adverse Events: A Single Center Experience
复制标题
DOI：
10.3121/cmr.2017.1364
复制
发表时间：
2018-06-01
影响因子：
1.4
通讯作者：
Cutlan, Jonathan E.
中科院分区：
文献类型：
--
作者：
Sehgal, Rahul;Stratman, Erik J.;Cutlan, Jonathan E.
生物制剂被认为是多种自身免疫性疾病的有效治疗方法。这些药物具有可接受的安全性和耐受性，尽管越来越多的自身免疫性疾病已被报告使用。此外，多种皮肤疾病也与它们的使用有关。在这里，我们报告我们的经验，不良皮肤事件与使用生物制剂。必须仔细研究患者出现不良皮肤事件（包括药物相互作用）的替代解释。
Biologic agents are regarded as an effective treatment for a variety of autoimmune diseases. These drugs have an acceptable safety and tolerability profile, although an increasing number of autoimmune conditions have been reported with their use. Additionally, a variety of cutaneous diseases have been associated with their use. Here we report our experience of adverse cutaneous events with the use of biologic agents. An alternative explanation for patients presenting with adverse cutaneous events including drug interactions must be carefully investigated.